News

Genoskin is thrilled to welcome Dr. Florent Ginhoux, PhD, to its Scientific Advisory Board (SAB). After last year’s nomination of world-renowned immunology expert, Dr. Nicolas Gaudenzio, as Genoskin’s CSO, Dr. Ginhoux will now bring his world-class expertise as Highly Cited Researcher in tissue-resident immune cell biology and associated pathophysiological responses to the table.

GENOSKIN CSO OBTAINS HIGH-PROFILE CAREER AWARD To start the new year in good cheer, Genoskin is proud to announce that Dr. Nicolas Gaudenzio, our Chief Scientific Officer and Principal Investigator at Infinity, has recently obtained the Arloing-Courmont-Pasteur Institute career achievement award in human biology from the Academy of Science in Lyon, France. An award to highlight innovative scientific research TheRead more

Genoskin launches MANTIS^®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS^® (Multiplex ANnotated Tissue Imaging System) platform was developed at Infinity (Inserm U1291, France) by a team of experts under the guidance of Dr. Nicolas Gaudenzio, who was recently appointed as our Chief Scientific Officer (CSO).

Dr. Gaudenzio is a world-renowned researcher and expert in immunology and allergic skin inflammation. He is also principal investigator and leader of a research group at the Infinity Institute (Toulouse Institute for Infectious and Inflammatory Diseases, France), which focuses on the neuronal regulation of immune response.

Genoskin announces the launch of the ISR platform^®, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ahead of clinical trials.

10 Year Anniversary: Interview with Pr. Guy Serre For our 10th anniversary, we spoke to people who helped Genoskin become what it is today. Back in March, we had a chat with Pr. Guy Serre, Director of the UDEAR lab (Epidermis Differentiation and Rheumatoid Autoimmunity Unit), the place where Genoskin was born. Genoskin: Could you describe the relationship between yourRead more